197 related articles for article (PubMed ID: 35693625)
21. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
[TBL] [Abstract][Full Text] [Related]
22. SGLT2 inhibitors vs. GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation.
Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Yeh YH; Kuo CT; See LC; Lip GYH
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38466894
[TBL] [Abstract][Full Text] [Related]
23. The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.
Ling AW; Chan CC; Chen SW; Kao YW; Huang CY; Chan YH; Chu PH
Cardiovasc Diabetol; 2020 Nov; 19(1):188. PubMed ID: 33158436
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
[TBL] [Abstract][Full Text] [Related]
25. Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation.
Oraii A; Healey JS; Benz AP; Pandey AK; Wong JA; Fonguh S; Wang J; Conen D; Gerstein HC; Connolly SJ; McIntyre WF
Can J Cardiol; 2022 Sep; 38(9):1434-1441. PubMed ID: 35562018
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.
Haywood LJ; Davis BR; Piller LB; Simpson LM; Ghosh A; Einhorn PT; Ford CE; Probstfield JL; Soliman EZ; Wright JT;
J Natl Med Assoc; 2018 Aug; 110(4):343-351. PubMed ID: 30126559
[TBL] [Abstract][Full Text] [Related]
27. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
[TBL] [Abstract][Full Text] [Related]
28. Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosis.
Ermert L; Kreimer F; Quast DR; Pflaumbaum A; Mügge A; Gotzmann M
Front Cardiovasc Med; 2022; 9():940060. PubMed ID: 36712260
[TBL] [Abstract][Full Text] [Related]
29. Atrial Fibrillation or Flutter During Pregnancy in Patients With Structural Heart Disease: Data From the ROPAC (Registry on Pregnancy and Cardiac Disease).
Salam AM; Ertekin E; van Hagen IM; Al Suwaidi J; Ruys TPE; Johnson MR; Gumbiene L; Frogoudaki AA; Sorour KA; Iserin L; Ladouceur M; van Oppen ACC; Hall R; Roos-Hesselink JW
JACC Clin Electrophysiol; 2015 Aug; 1(4):284-292. PubMed ID: 29759316
[TBL] [Abstract][Full Text] [Related]
30. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation.
Nabar A; Rodriguez LM; Timmermans C; van den Dool A; Smeets JL; Wellens HJ
Circulation; 1999 Mar; 99(11):1441-5. PubMed ID: 10086967
[TBL] [Abstract][Full Text] [Related]
31. Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter.
Hu WS; Lin CL
Korean Circ J; 2020 Jun; 50(6):527-532. PubMed ID: 32281320
[TBL] [Abstract][Full Text] [Related]
32. Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter.
Celikyurt U; Knecht S; Kuehne M; Reichlin T; Muehl A; Spies F; Osswald S; Sticherling C
Europace; 2017 Nov; 19(11):1776-1780. PubMed ID: 28069839
[TBL] [Abstract][Full Text] [Related]
33. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Kipp R; Askari M; Fan J; Field ME; Turakhia MP
JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
[TBL] [Abstract][Full Text] [Related]
34. Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.
Luria DM; Hodge DO; Monahan KH; Haroldson JM; Shen WK; Asirvatham SJ; Hammill SC; Munger TM; Glikson M; Gersh BJ; Packer DL; Friedman PA
J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1145-50. PubMed ID: 18554204
[TBL] [Abstract][Full Text] [Related]
35. Sodium glucose cotransporter 2 inhibitors with cardiac arrhythmias in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized placebo-controlled trials.
Xu B; Kang B; Zhou J
Clin Res Cardiol; 2024 Jun; 113(6):910-923. PubMed ID: 38353684
[TBL] [Abstract][Full Text] [Related]
36. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ
JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707
[TBL] [Abstract][Full Text] [Related]
37. Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials.
Fernandes GC; Fernandes A; Cardoso R; Penalver J; Knijnik L; Mitrani RD; Myerburg RJ; Goldberger JJ
Heart Rhythm; 2021 Jul; 18(7):1098-1105. PubMed ID: 33757845
[TBL] [Abstract][Full Text] [Related]
38. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
[TBL] [Abstract][Full Text] [Related]
39. Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation.
Staszewski J; Bilbin-Bukowska A; Szypowski W; Mejer-Zahorowski M; Stępień A
Arch Med Sci; 2021; 17(6):1590-1598. PubMed ID: 34900038
[TBL] [Abstract][Full Text] [Related]
40. The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor.
Chan YH; Chen SW; Chao TF; Kao YW; Huang CY; Chu PH
Cardiovasc Diabetol; 2021 Apr; 20(1):93. PubMed ID: 33941171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
